- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05537259
BUMPP: A Study to Better Understand Mood During the Perinatal Period (BUMPP)
November 15, 2023 updated by: University of Minnesota
The overall goal of the BUMPP study is to improve our understanding of a range of moods, feelings, and thoughts that women can experience during pregnancy and soon after they give birth.
This study will examine how these moods, feelings, and thoughts are related to changes in hormonal and immune health that women experience during and after pregnancy, and to mother-baby relationships and infant development in the early postpartum months.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
168
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- University of Minnesota
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Pregnant women and their infants
Description
Inclusion Criteria:
- 18 years or older
- 35 weeks pregnant or less
- carrying only one baby (not twins or triplets)
- first time giving birth
- can speak/read/write in English
Exclusion Criteria:
- major medical health condition like a heart, kidney, or liver disease or HIV
- currently taking corticosteroids, progesterone, or immunosuppressive medications that might impact the samples we are taking in this research study
- have regularly used alcohol, tobacco, or recreational drugs (such as marijuana or prescription drugs for non-medical reasons) during pregnancy (regularly means more than a few times total, such as on a monthly, weekly, or daily basis)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Observation Group
Researchers will collect data on maternal mental health symptoms, as well as health and psychosocial factors, via short interviews (sessions 1 and 4) and via self-report questionnaires completed through REDCap at each session.
Participating women will also provide one small hair sample (session 4) for measurement of the stress hormone cortisol and several finger stick blood spot samples (sessions 1,2, and 4) for measurement of immune markers.
|
No intervention; this is an observational study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-report questionnaire measure of depressive symptoms (Edinburgh Postnatal Depression Scale)
Time Frame: 35 weeks of pregnancy through 2 months postpartum
|
Assessed at each of 4 sessions
|
35 weeks of pregnancy through 2 months postpartum
|
Self-report questionnaire measure of anxiety symptoms (Generalized Anxiety Disorder-7)
Time Frame: 35 weeks of pregnancy through 2 months postpartum
|
Assessed at each of 4 sessions
|
35 weeks of pregnancy through 2 months postpartum
|
Self-report questionnaire measure of manic symptoms (Highs Scale)
Time Frame: 35 weeks of pregnancy through 2 months postpartum
|
Assessed at each of 4 sessions
|
35 weeks of pregnancy through 2 months postpartum
|
Self-report questionnaire measure of symptoms of psychosis (subscales of Symptom Checklist-90)
Time Frame: 35 weeks of pregnancy through 2 months postpartum
|
Assessed at each of 4 sessions
|
35 weeks of pregnancy through 2 months postpartum
|
Mother-infant behavior during 5 min play episode coded using Global Rating Scales
Time Frame: 2 months postpartum
|
Assessed at in-person laboratory session (session 4)
|
2 months postpartum
|
Bayley Scales of Infant Development, 4th edition, to assess infant cognitive development
Time Frame: 2 months postpartum
|
Assessed at in-person laboratory session (session 4)
|
2 months postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Monthly cortisol levels determined from hair sample
Time Frame: 35 weeks of pregnancy through 2 months postpartum
|
1 sample at session 4
|
35 weeks of pregnancy through 2 months postpartum
|
Cytokine levels determined from finger prick blood spot
Time Frame: 35 weeks of pregnancy through 2 months postpartum
|
3 samples (sessions 1, 2, and 4)
|
35 weeks of pregnancy through 2 months postpartum
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Megan Gunnar, PhD, University of Minnesota
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 27, 2022
Primary Completion (Actual)
November 7, 2023
Study Completion (Estimated)
November 7, 2024
Study Registration Dates
First Submitted
July 6, 2022
First Submitted That Met QC Criteria
September 11, 2022
First Posted (Actual)
September 13, 2022
Study Record Updates
Last Update Posted (Estimated)
November 16, 2023
Last Update Submitted That Met QC Criteria
November 15, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 31077
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium
-
Turku University HospitalUniversity of TurkuCompleted
-
Hopital Antoine BeclereUnknown
Clinical Trials on Observation Group
-
Aristotle University Of ThessalonikiGeneral Hospital Of Thessaloniki IppokratioRecruitingAtrial Fibrillation | Atrial ArrhythmiaGreece
-
ConaviCompletedAcute Coronary Syndrome | Stable AnginaCanada
-
University Hospital, MontpellierCentre Hospitalier Universitaire de NīmesCompletedSchizophrenia | Schizoaffective DisorderFrance
-
IRCCS San Raffaele RomaCompleted
-
University of Colorado, DenverNational Center for Advancing Translational Sciences (NCATS); Colorado Clinical...Completed
-
University of Alabama at BirminghamNot yet recruitingSickle Cell Disease | Breastfeeding | Adverse Childhood ExperiencesUnited States
-
Universidad Autonoma de MadridCentro Universitario La SalleUnknownMovement, InvoluntarySpain
-
Zonguldak Bulent Ecevit UniversityCompletedDeglutition Disorders | Rehabilitation | Neurogenic DysphagiaTurkey
-
Prof. Dr. Cemil Tascıoglu Education and Research...UnknownAnkle Fractures | Proximal Humeral Fracture | Wrist FractureTurkey
-
Queen Mary University of LondonBarts & The London NHS Trust; East London NHS Foundation TrustCompletedMental Health | Learning Disability, AdultUnited Kingdom